Saniona announces succesful completion of preclinical development of SAN711
Clinical Research | News | 0 Comment | 19 Feb, 2019
Saniona, a biotech company focused on CNS and eating disorders has announced the successful completion of preclinical de...Read more
Navitas Life Sciences acquires DataCeutics in a $45 MM deal
Clinical Research | News | 0 Comment | 14 Feb, 2019
Navitas Life Sciences, a TAKE Solutions Enterprise has announced that it will be acquiring Life Sciences services player...Read more
Boehringer Ingelheim, IBM to integrate blockchain tech in clinical trials
Clinical Research | News | 0 Comment | 14 Feb, 2019
Boehringer Ingelheim (Canada) Ltd. and IBM Canada have announced at the Healthcare Information and Management Systems So...Read more
Pfizer, Astellas announce results from Ph 3 ARCHES trial in men with mHSPC
Clinical Research | News | 0 Comment | 12 Feb, 2019
Pfizer Inc. and Astellas Pharma Inc. have announced the results from the Phase 3 ARCHES trial in men with metastatic hor...Read more
“An efficient approach to clinical trial design will have the greatest impact”
Clinical Research | Opinion | 3 Comment | 06 Feb, 2019
The annual J.P. Morgan Healthcare Conference is the premier investor conference focused exclusively on companies definin...Read more
TLC appoints George Spencer-Green as CMO
Clinical Research | News | 0 Comment | 05 Feb, 2019
Taiwan Liposome Company, a clinical-stage specialty pharmaceutical company dedicated to the development and commercializ...Read more
Eisai, Purdue Pharma announce significant data of ph 3 clinical study
Clinical Research | News | 0 Comment | 04 Feb, 2019
Eisai Co., Ltd. and Purdue Pharma L.P. announced a six-month results from SUNRISE 2, a long-term Phase 3 clinical study ...Read more
Spero Therapeutics announces initiation of SPR720 Ph 1 Clinical Trial
Clinical Research | News | 0 Comment | 31 Jan, 2019
Spero Therapeutics, a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and ...Read more
Ionis, Roche initiates pivotal study of RG6042 for Huntington's disease
Clinical Research | News | 0 Comment | 30 Jan, 2019
Ionis Pharma, Inc. the leader in antisense therapeutics, has announced that its partner Roche has enrolled the firs...Read more
NIAID-sponsored trial of Ebola vaccines begins at Cincinnati Children's Hospital
Clinical Research | News | 0 Comment | 29 Jan, 2019
A Phase 1 clinical trial of investigational vaccines intended to protect against Zaire ebolavirus (Ebola) is underway at...Read more
Dicerna announces start of Ph1 clinical trial of DCR-HBVS
Clinical Research | News | 0 Comment | 29 Jan, 2019
Dicerna Pharmaceuticals, a leading developer of RNA interference (RNAi) therapeutics, today announced the dosing of the ...Read more
OliX announces clinical candidate for Geographic Atrophy treatment
Clinical Research | News | 0 Comment | 29 Jan, 2019
OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, has announced the nomination of OLX10020 as a clin...Read more
Translate Bio announces FDA clinical hold on IND
Clinical Research | News | 0 Comment | 23 Jan, 2019
Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transfor...Read more
Gamida Cell collaborates with Be The Match BioTherapies
Clinical Research | News | 0 Comment | 23 Jan, 2019
Clinical stage Biopharmaceutical Company, Gamida Cell Ltd. and Be The Match BioTherapies, a subsidiary of the National M...Read more
Redx to resume RXC004 clinical trial programme
Clinical Research | News | 0 Comment | 22 Jan, 2019
UK based Biotechnology Company, Redx has announced that the UK’s Medicines and Healthcare products Regulatory Agen...Read more
Abcam, Loulou Foundation enters research collaboration for CDKL5 deficiency disorder
Clinical Research | News | 0 Comment | 22 Jan, 2019
Abcam, a global innovator in life science reagents and tools, and the Loulou Foundation, a private UK-based foundation d...Read more
TaiwanJ Pharma announces new clinical results on AIH drug
Clinical Research | News | 0 Comment | 22 Jan, 2019
TaiwanJ Pharmaceuticals, a specialty pharmaceutical company dedicated to the development and commercialization of small ...Read more
Lilly reports results of ANNOUNCE
Clinical Research | News | 0 Comment | 21 Jan, 2019
Eli Lilly and Company has reported that the results of ANNOUNCE, the Phase 3 study of LARTRUVO (olaratumab), in combinat...Read more